Why the study?
Traditional population-based risk stratification and standardised treatment protocols often fail to capture individual patient variability in cardiovascular diseases, prompting evaluation of digital twins as a paradigm shift toward precision medicine.
Design
Narrative review of peer-reviewed literature, regulatory guidance documents, and industry white papers
Key result
Cardiac digital twins demonstrate feasibility and emerging clinical utility across multiple cardiovascular domains, but widespread clinical adoption requires prospective randomized trials evaluating patient-centered outcomes.
Authors
Loading...
Digital twins may enable individualized CV management; leaves open prospective validation before clinical adoption.
Cardiac digital twins are transitioning from research tools to translational applications with tangible clinical potential, though prospective outcome validation is required for widespread adoption.
Olawade et al. (2026) conducted a review in Cardiovascular diseases. Cardiac digital twins vs. Conventional clinical approaches was evaluated. Cardiac digital twins demonstrate feasibility and emerging clinical utility across multiple cardiovascular domains, but widespread clinical adoption requires prospective randomized trials evaluating patient-centered outcomes.